1. Home
  2. PGY vs FTRE Comparison

PGY vs FTRE Comparison

Compare PGY & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pagaya Technologies Ltd.

PGY

Pagaya Technologies Ltd.

HOLD

Current Price

$18.43

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$21.67

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGY
FTRE
Founded
2016
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.9B
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
PGY
FTRE
Price
$18.43
$21.67
Analyst Decision
Strong Buy
Buy
Analyst Count
11
13
Target Price
★ $28.91
$20.67
AVG Volume (30 Days)
★ 2.3M
1.3M
Earning Date
11-09-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 116.43
N/A
EPS
★ 0.77
N/A
Revenue
$1,301,360,000.00
★ $2,723,400,000.00
Revenue This Year
$12.53
N/A
Revenue Next Year
$15.85
$3.05
P/E Ratio
$23.91
★ N/A
Revenue Growth
★ 26.07
1.00
52 Week Low
$10.40
$8.55
52 Week High
$31.54
$21.39

Technical Indicators

Market Signals
Indicator
PGY
FTRE
Relative Strength Index (RSI) 42.15 66.37
Support Level $16.34 $15.94
Resistance Level $19.14 N/A
Average True Range (ATR) 0.99 1.08
MACD -0.21 0.15
Stochastic Oscillator 31.57 58.86

Price Performance

Historical Comparison
PGY
FTRE

About PGY Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Share on Social Networks: